Phase II study of fixed-dose-rate infusion of gemcitabine and UFT combination chemotherapy in patients with advanced bile duct cancer: Daegu Gyeoungbuk Oncology Group.
Hun-Mo Ryoo
Disclosure not yet available
Sung Hwa Bae
Disclosure not yet available
Min Kyoung Kim
Disclosure not yet available
Kyung Hee Lee
Disclosure not yet available
Hong-Suk Song
Disclosure not yet available
Yee Soo Chae
Disclosure not yet available
Won Sik Lee
Disclosure not yet available
Jin Ho Baek
Disclosure not yet available